Algernon Pharmaceuticals Inc (AGNPF)

[tcm7]

I wonder about the style of Ifenprodil that will be used in the SK trials. Will it be some kind of a pill or the new formulated intravenous method? Either way looks like AGN has a plan and something stashed away to use...GLTA...

Algernon Pharmaceuticals Inc. and subsidiary Nash Pharmaceuticals Set aside drug supply of NMDA antagonist for compassionate use from phase II study for idiopathic fibrosis and chronic cough based on an independent study that showed a 40% improvement in mortality and significantly reduced acute lung injury (ALI) in an independent H5N1 animal study; originally developed as Cerocal by Sanofi SA to treat circulatory disorders in the French and Japanese markets; company is beginning production with a new injectable and long-acting oral release formulation, in order to be prepared for new U.S. clinical trials for COVID-19 and ALI. Algernon announced that CRO Novotech had identified physicians in South Korea who have agreed to conduct a phase II trial of ifenprodil for coronavirus patients; as of April 2, protocol finalized for physician-initiated study in South Korea with submission for approval ."

and of course the Trials start by May 8 th at the latest, so recruitments of patients are under way right now possibly. Also of course there must be some of the drugs available...GLTA...